See the DrugPatentWatch profile for Zileuton
What is zileuton, and why does production cost vary?
Zileuton is a prescription drug used for asthma control. Production cost is not a single fixed number because it depends on the active pharmaceutical ingredient (API) route, yields, solvent and reagent costs, purity specs, manufacturing scale, and regulatory requirements for quality systems and batch release testing.
What do we know from the provided information?
No production-cost figures or manufacturing economics for zileuton are included in the information provided here, so a specific “per kg,” “per tablet,” or “per dose” production-cost estimate can’t be calculated from available data.
How are drug production costs typically estimated (if you’re doing research)?
When people estimate production cost for a specific API like zileuton, they usually combine:
- API synthesis costs (raw materials, reagents, catalysts, solvents, purification steps, and waste disposal)
- Finished-dose costs (formulation, tableting/encapsulation, packaging)
- Quality and compliance costs (GMP batch controls, stability testing, validation)
- Overheads and yields (facility cost allocation and how often batches meet specs)
Public figures that sometimes help include API cost disclosures, generic drug applications (where available), and market reports on API and finished-dose supply chains. None of those sources or figures were provided in your prompt.
Can you share what kind of cost you need?
If you tell me whether you want:
- API-only (cost per kg of zileuton API),
- finished product (cost per tablet/capsule),
- a rough industry benchmark range, or
- the cost structure (what drives the biggest portion),
I can format the answer to match your goal.